Business Insights, June 2011, Pages: 160
position in the cardiovascular segment and what are their growth strategies? Executive Summary Overview and epidemiology of cardiovasculardisorders Global market analysis Pipeline analysis Competitive
Bizacumen Inc., Nov 2009, Pages: 179
increased risk of cardiovascular disease (CVD) and abnormally high levels of cholesterol or lipid disorders. Rising levels of awareness and growing health consciousness among adults and at-risk patient
Global Industry Analysts, Inc., Feb 2011, Pages: 293
10
Types of Cardiovascular Diseases/Disorders 10
Coronary Artery Disease 10
Hyperlipidemia - An Important
Business Insights, April 2008, Pages: 265
in vitro diagnostics market
Outlook for the diagnostic biomarkers market
Cancer: immunoassays and microarrays
Cardiovascular disease: immunoassays
Infection biomarkers
Predisposition and pharmacogenomic
Decision Resources, Inc., May 2009, Pages: 40
.
- U.S. healthcare expenditures: total healthcare expenditures, healthcare expenditures as a percentage of GDP, sources of healthcare expenditure.
- Therapeutic areas affecting the elderly: cardiovascular
UBM Canon, April 2011, Pages: 23
. These therapeutic fields include cardiovascular conditions, HIV, diabetes, mental-health disorders, arthritis, osteoporosis, multiple sclerosis, psoriasis, and hepatitis. - Introduction to the Investigational Drug
Frost & Sullivan, Sep 2009, Pages: 51
: cardiovascular diseases, central nervous system disorders, diabetes, oncology and respiratory disorders.
Market Overview
Niche Growth Segments to Offer Potential for Participants in the Global Active
Business Insights, Oct 2006, Pages: 199
, treatments for cardiovasculardisorders continue to remain popular among specialty pharmaceutical companies. This indication generated revenues of $4,600m in 2005 with anti-hypertensives accounting for $1.2bn
Frost & Sullivan, March 2011, Pages: 119
diseases across the globe has increased the demand for devices for monitoring cardiovasculardisorders. The equipment used for diagnoses include Resting ECG, Stress ECG, Holter monitor, Cardiac Event
Spectra Intelligence, Jan 2006, Pages: 580
and Market Outlook
Drugs in Research and Development for Androgen Deficiency and Andropause
Future Considerations for Drugs to Treat Androgen Deficiencies Associated with Sexual Disorders and Andropause
- Male
Spectra Intelligence, Sep 2007, Pages: 350
.2.1.1 Product Analysis of Leading Contraceptives 266
6.2.1.2 Market Outlook and Summary for Contraceptives 266
6.3 Menstrual Disorders 272
6.3.1 The Global Market for Menstrual Disorders, 2007-2017 273
6
Decision Resources, Inc., Aug 2008, Pages: 47
drug sales.
Cardiovascular diseases, metabolic disorders, infectious diseases, immune/inflammatory disorders, and several other key conditions account for a substantial share of Medicare Part D
RNCOS E-Services Private Limited, Dec 2011, Pages: 60
RNA Market Outlook”, the global research on miRNA is expected to grow at a stupendous rate in the coming years. Both, private and public sectors are stepping forward to provide huge financial support to fund
Frost & Sullivan, Sep 2010, Pages: 81
, cardiovasculardisorder, chronic illness across the globe has increased the demand for devices for monitoring vital parameter for patients. The economic down turn had slowed the European leasing industry. However
Frost & Sullivan, March 2008, Pages: 57
segments: cardiovascular devices, orthopedic devices, general surgery, endoscopy, neurology devices, urology and gynecology, ophthalmic equipment, cosmetics and aesthetics, hearing and audiology, wound care
Global Industry Analysts, Inc., Oct 2011, Pages: 375
.5 million people in the US alone suffer from cardiac disorders. Heart disease is one of the world’s leading life-threatening conditions, affecting a large part of the population, particularly among aged
Decision Resources, Inc., June 2008, Pages: 66
, including 20 products in each of 7 therapeutic areas (cardiovascular disease, metabolic disorders, immune/infl ammatory disorders, infectious disease, neurology, psychiatry, and oncology), 10 treatments
